Lv71
4485 积分 2020-08-27 加入
AURKB drives aggressive phenotype and clinicopathological progression in cholangiocarcinoma
2小时前
求助中
PARG inhibition halts cholangiocarcinoma progression via the Hippo pathway and enhances response to chemotherapy and immunotherapy
1个月前
已完结
PARG inhibition halts cholangiocarcinoma progression via the Hippo pathway and enhances response to chemotherapy and immunotherapy
1个月前
已完结
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
3个月前
已完结
CAF-derived LRRC15 orchestrates macrophage polarization and limits PD-1 immunotherapy efficacy in glioblastoma
3个月前
已完结
Interpretable multimodal deep learning improves postoperative risk stratification in intrahepatic cholangiocarcinoma in multicentre cohorts
4个月前
已完结
Guidelines for T cell nomenclature
5个月前
已完结
CD19 CAR T-cell Clinical Outcome Is Associated with the Gut Microbiome
5个月前
已完结
Tumor-derived CD109 orchestrates reprogramming of tumor-associated macrophages to dampen immune response
5个月前
已完结
Comparative Genomic Analysis and Clinical Outcomes of BRAF-mutated Advanced Biliary Tract Cancers
5个月前
已完结
皖公网安备34019202002308
